Novo, Lundbeck and Leo defend vilified sales methods
One of the world’s biggest pharma players has shelved its sternly criticized sales methods to avoid having its integrity questioned due to unethical financial incentives, which could ultimately prove harmful to patients. But Novo Nordisk, Lundbeck and Leo Pharma are standing up for those very same methods.
by Leonora Beck
Is it ethically right for the pharmaceutical industry to pay sales personnel based on how much medicine they manage to convince doctors to prescribe? And is it okay for companies to pay doctors to promote their products and offer doctors financial incentives to participate in conferences?
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Novo’s corporate culture is a powerful weapon in China
For abonnenter
Novo wants to secure reputation through data access
For abonnenter
Doctors represent hurdle for Lundbeck once again
For abonnenter
